Vertex Pharmaceuticals Inc / Ma

MetLife Investment Management, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

73,281

Value ($000)

33,223

Weight

0.2%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	33,223	0.2%	73,281	12/31/2025
2025 Q3	11/13/2025	29,689	0.1%	75,807	9/30/2025
2025 Q2	8/13/2025	34,346	0.2%	77,148	6/30/2025
2025 Q1	5/14/2025	35,082	0.2%	72,361	3/31/2025
2024 Q4	2/13/2025	29,753	0.2%	73,884	12/31/2024
2024 Q3	11/13/2024	33,956	0.2%	73,011	9/30/2024
2024 Q2	8/13/2024	35,079	0.2%	74,839	6/30/2024
2024 Q1	5/14/2024	29,298	0.2%	70,090	3/31/2024
2023 Q4	4/22/2024	29,406	0.2%	72,271	12/31/2023
2023 Q3	5/9/2024	25,612	0.2%	73,654	9/30/2023
2023 Q2	4/29/2024	26,463	0.2%	75,198	6/30/2023
2023 Q1	5/9/2024	23,933	0.2%	75,960	3/31/2023
2022 Q4	5/10/2024	22,131	0.2%	76,636	12/31/2022
2022 Q3	5/10/2024	22,608	0.2%	78,083	9/30/2022
2022 Q2	5/10/2024	22,203	0.2%	78,794	6/30/2022
2022 Q1	5/10/2024	19,266	0.1%	73,825	3/31/2022
2021 Q4	5/17/2024	12,336	0.1%	56,175	12/31/2021
2021 Q3	5/17/2024	10,628	0.1%	58,594	9/30/2021
2021 Q2	5/17/2024	12,101	0.1%	60,016	6/30/2021
2021 Q1	5/17/2024	13,312	0.1%	61,949	3/31/2021
2020 Q4	5/24/2024	14,925	0.1%	63,151	12/31/2020
2020 Q3	5/24/2024	17,971	0.2%	66,040	9/30/2020
2020 Q2	5/24/2024	19,686	0.2%	67,811	6/30/2020
2020 Q1	7/12/2023	15,772	0.2%	66,284	3/31/2020
2019 Q4	7/12/2023	14,957	0.2%	68,312	12/31/2019
2019 Q3	7/12/2023	11,851	0.1%	69,949	9/30/2019
2019 Q2	7/12/2023	12,946	0.1%	70,597	6/30/2019
2019 Q1	7/13/2023	13,368	0.2%	72,673	3/31/2019
2018 Q4	7/13/2023	12,111	0.2%	73,084	12/31/2018
2018 Q3	7/13/2023	14,329	0.2%	74,343	9/30/2018